Paracrine Therapeutics (PT) is a biopharmaceutical company focused on development of stem exosome for regenerative medicine. PT has exclusive license to an extensive patent portfolio that covers the production, composition and use of exosomes from A*STAR. 

Exosome: The New Paradigm in Stem Cell Biology

Scientists have recently discovered that stem cells secrete small vesicles known as EXOSOMES to exert many of its regenerative effects. Exosomes are rich in proteins and nucleic acids, and have many functions of a stem cell.  But unlike stem cells, they are not living and cannot grow to become unwanted tissues such as tumors.

New Disruptive and Safer Therapeutic for Regenerative Medicine

Stem cell EXOSOMES can be easily harvested, stored frozen and thawed to immediately meet the patient’s need. Patients and clinicians no longer have to wait for stem cells to be harvested and grown or worry if cells would survive the freeze-thaw and transplantation, and if the cells would grow into unwanted tissues.

Proprietary Exosome Technology Platform

Our exosome technology platform covers the full spectrum of production, composition and use that is underpinned by an extensive patent portfolio.

logo

"Living well with stem cell exosomes"